- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00765388
A Randomised Cross-over Study With Two 1-piece Urostomy Bags. (DK188OS)
A Comparative, Randomised, Crossover Study With 2 Urostomy Bags Among 30 Urostomy-operated Persons in UK
Background Urostomy is a surgical procedure that detours or diverts urine away form a diseased or defective bladder. The bladder can be removed and the urine is passed out of the body through an opening (stoma) in the stomach. People with urostomy will not be able to start and stop urine coming out through the stoma, so a urostomy bag will be fitted to collect the urine as it comes out.
A urostomy bag consists of an adhesive, which is attached to the skin around the stoma and a bag connected to the adhesive to collect the urine.
It is very important the standard is high on these products; otherwise the user (urostomy-patient) will experience lots of problems with the skin around the stoma.
Study Overview
Detailed Description
In this trial we are comparing two types of urostomy bags - the SenSura 1-piece and Hollisters Moderma Flex.
Both products are CE-marked, meaning that they are safe and approved in use for people with an urostomy.
Population 30 urostomy operated people from UK will participate in the trial. Only participants who normally use a flat 1-piece urostomy bag can participate. It is very important that the participants keep their normal use- and change pattern. Furthermore they need to be over 18 years old, have had the urostomy for more than 3 months, the size of the urostomy shall be between 15-55 mm, otherwise the bag will not fit them and then they should be able to handle the bags themselves and be willing to use the two products tested in the trial.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Brighton, United Kingdom
- Maureen Bridgland
-
Colchester, United Kingdom, CO45JL
- Michael Lynch
-
London, United Kingdom, WC1E 5DB
- University of London Hospital
-
Norwich, United Kingdom
- Theresa Bowles
-
-
Surrey
-
Chertsey, Surrey, United Kingdom, KT16OPZ
- St. Peters Hospital
-
-
Tooting
-
London, Tooting, United Kingdom, SW17OQT
- Caroline Rudoni
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
In order to be enrolled in the clinical investigation, the subject must:
- Be at least 18 years old,
- Be mentally and physically capable of signing the written consent form
- Be able to fill in the Case Report Form (questionnaire)
- Have an urostomy with a size between 15-55 mm.
- Have had the urostomy for 3 months or more,
- Use a 1-piece bag normally.
- Be able to handle the bag themselves (application and removal)
- Be willing to use Coloplast SenSura 1-piece bag
- Be willing to use Hollisters Moderma Flex, 1-piece bag
Exclusion Criteria:
In order to be enrolled in the clinical investigation, the subjects must not:
- Be a convex base plate user (i.e. a bowl-shaped adhesive which pushes the stoma forward)
- Need to use an ostomy belt
- Be currently suffering from any dermatologiacal problems, needing special treatment, in the peristomal area (investigator will evaluate skin according to a newly developed ostomy skin tool from Coloplast A/S)
- Being treated with chemo- or radiation therapy,
- Be hospitalized during study enrollment, or have a hospitalization or significant surgery planned during the 4-week study period, or
- Be pregnant or breast-feeding.
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: SenSura Uro
The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
|
The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
Other Names:
|
ACTIVE_COMPARATOR: hollister Uro
The comparator product is CE-marked and non-sterile and produced for urostomy operated.
It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive
|
The comparator product is CE-marked and non-sterile and produced for urostomy operated.
It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preference of Sensura vs Moderma
Time Frame: 4 weeks
|
Subjects were asked which of the tested products they preferred; SenSura or Moderma.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Immediate Adhesion
Time Frame: 4 weeks
|
Evaluation of immediate adhesion after each period
|
4 weeks
|
Removal of the Bag
Time Frame: 4 weeks
|
How easy/difficult it was to remove the bag
|
4 weeks
|
Adhesion of the Bag During Use
Time Frame: 4 weeks
|
Evaluation of the adhesion of the base plate around the stoma during use
|
4 weeks
|
Adhesives Ability to Absorb Perspiration
Time Frame: 4 weeks
|
Evaluation of the adhesives ability to absorb perspiration from the skin
|
4 weeks
|
Flexibility of the Product
Time Frame: 4 weeks
|
Evaluation of the ability of the bag to conform with the patients movements (flexibility)
|
4 weeks
|
Awareness of the Presence of the Product
Time Frame: 4 weeks
|
Evaluates the patients awareness of the presence of the product during use.
|
4 weeks
|
Feeling of Security During the Day
Time Frame: 4 weeks
|
The patients feeling of security with the bag during the day
|
4 weeks
|
Feeling of Security During the Night
Time Frame: 4 weeks
|
The patients feeling of security with the product during the night
|
4 weeks
|
Problems With Splashing Sounds During Use
Time Frame: 4 weeks
|
The patient was asked whether he/she noticed any splashinh sounds during use
|
4 weeks
|
Bag Twisting During Night
Time Frame: 4 weeks
|
The patient was asked if he/she noticed whether the bag twisted during night
|
4 weeks
|
Changes in Skin Compared to Before Study
Time Frame: 4 weeks
|
The patient was asked whether he/she experienced changes in the skin condition after testing the blue/red product
|
4 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Carol Katte, Stoma Nurse, Ashford and St. Peters Hospital
- Principal Investigator: Maureen Bridgland, Stoma Nurse, Royal Sussex County Hospital
- Principal Investigator: Caroline Rudoni, Stoma Nurse, St. Georges Hospital
- Principal Investigator: Theresa Bowles, Stoma Nurse, Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
- Principal Investigator: Michael Lynch, Surgeon, Colchester General Hospital
- Principal Investigator: Sharon Fillingham, Nurse, UCLH
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- DK188OS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urostomy
-
ConvaTec Inc.UnknownColostomy | Ileostomy | UrostomyPoland
-
University of Kansas Medical CenterCompletedBladder Cancer | UrostomyUnited States
Clinical Trials on SenSura Uro
-
Coloplast A/SCompletedStoma IleostomyFrance, Denmark, United Kingdom, Germany, Norway
-
Coloplast A/SCompleted
-
Coloplast A/SCompletedIleostomy - StomaBelgium, Denmark, Norway, Netherlands, Sweden
-
Coloplast A/SCompletedIleostomy - StomaSweden
-
Coloplast A/SLægernes Test Center A/SCompleted
-
Coloplast A/SCompletedIleostomy - StomaDenmark
-
Weill Medical College of Cornell UniversityLaborie Medical Technologies Inc.; Urodynamix TechnologiesCompleted